---
schema_version: "secwatch.filing_event.v1"
accession: "0001872789-24-000016"
form_type: "8-K"
ticker: "EMBC"
cik: "0001872789"
company_name: "Embecta Corp."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T07:10:39.548615+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Embecta Q2 revenue up 3.6% to $287.2M; raises FY2024 guidance above prior range

## Summary
- Revenue of $287.2M (+3.6% reported, +4.5% constant currency); U.S. +0.8%, International +6.8%.
- Adjusted EPS of $0.67 vs $0.75 prior year; adjusted operating margin of 26.1% vs 30.6%.
- Raised FY2024 guidance: revenue $1,111-1,116M (prev. $1,094-1,116M), adj. EPS $2.20-2.30 (prev. $1.95-2.15).
- FDA continues review of insulin patch pump 510(k); ERP implementation covers ~85% of revenue.
- Declared quarterly dividend of $0.15/share, payable June 14, 2024 to holders of record May 28, 2024.

## SEC filing metadata
- accession: 0001872789-24-000016
- form_type: 8-K
- ticker: EMBC
- cik: 0001872789
- company_name: Embecta Corp.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1872789/000187278924000016/0001872789-24-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1872789/000187278924000016/embc-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001872789-24-000016
- JSON: https://secwatch.observer/filing/0001872789-24-000016.json
- Plain text: https://secwatch.observer/filing/0001872789-24-000016.txt

## Key facts
- Earnings Releases
  Embecta Corp. reported three and six month periods ended March 31, 2024 results: revenue $287.2 million, net income $28.9 million, EPS $0.50. Guidance raised.
  - Period: three and six month periods ended March 31, 2024
  - Revenue: $287.2 million
  - Net income: $28.9 million
  - EPS: $0.50
  - Guidance: raised
  - Result: reported results
  source text: half of the year, we are raising and tightening our fiscal 2024 outlook for our key financial metrics." Second Quarter Fiscal Year 2024 Financial Highlights : • Revenues of $287.2 million, up 3.6% on a reported basis; up 4.5% on a constant currency basis ◦ U.S. revenues increased 0.8% on both a reported and constant currency basis ◦ International revenues
  evidence_url: https://www.sec.gov/Archives/edgar/data/1872789/000187278924000016/0001872789-24-000016-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.